Dunn Julia P, Abumrad Naji N, Kessler Robert M, Patterson Bruce W, Li Rui, Marks-Shulman Pamela, Tamboli Robyn A
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Veterans Administration St. Louis Health Care System, St. Louis, Missouri, USA.
Obesity (Silver Spring). 2017 Nov;25(11):1910-1915. doi: 10.1002/oby.22023. Epub 2017 Sep 25.
It has been previously reported that early after Roux-en-Y-gastric bypass, dopamine (DA) type 2 and 3 receptor (D2/3R) binding potential (BP ) was decreased from preoperative levels. The current study aimed to determine whether calorie restriction without weight loss modifies D2/3R BP and whether such changes are explained by neuroendocrine regulation.
Fifteen females with obesity (BMI = 39 ± 6 kg/m ) were studied before and after ∼10 days of a very-low-calorie-diet (VLCD). Outcome measures included fasting insulin, leptin, acyl ghrelin, and glucose, and insulin sensitivity and disposition index were estimated using the oral-minimal model (OMM) method. Participants underwent positron emission tomography scanning with the displaceable radioligand [ F]fallypride to estimate available regional D2/3R levels. Regions of interest included the caudate, putamen, ventral striatum, hypothalamus, and substantia nigra (SN).
With the VLCD, weight decreased slightly (-3 kg). Insulin, glucose, and leptin decreased significantly, but there was no change in acyl ghrelin or measures from OMM. SN D2/3R BP decreased significantly, with trends toward decreased levels in the remaining regions. The decrease in leptin concentration strongly predicted the change in D2/3R BP in all regions (all P ≤ 0.004).
In obesity, reductions in regional D2/3R availability after VLCD are suggestive of increased endogenous DA competing with the radioligand. Changes in regional D2/3R availability were associated with decreases in leptin concentrations that occurred before clinically significant weight loss.
先前有报道称,在Roux-en-Y胃旁路术后早期,多巴胺(DA)2型和3型受体(D2/3R)结合潜能(BP)较术前水平降低。本研究旨在确定无体重减轻的热量限制是否会改变D2/3R BP,以及这种变化是否可由神经内分泌调节来解释。
对15名肥胖女性(BMI = 39 ± 6 kg/m²)在进行约10天的极低热量饮食(VLCD)前后进行研究。结果指标包括空腹胰岛素、瘦素、酰基胃泌素和葡萄糖,并使用口服最小模型(OMM)方法评估胰岛素敏感性和处置指数。参与者接受了用可置换放射性配体[¹¹C]法利哌酮进行的正电子发射断层扫描,以估计可用的局部D2/3R水平。感兴趣的区域包括尾状核、壳核、腹侧纹状体、下丘脑和黑质(SN)。
采用VLCD后,体重略有下降(-3 kg)。胰岛素、葡萄糖和瘦素显著降低,但酰基胃泌素或OMM测量值无变化。SN的D2/3R BP显著降低,其余区域有降低趋势。瘦素浓度的降低强烈预测了所有区域D2/3R BP的变化(所有P≤0.004)。
在肥胖症中,VLCD后局部D2/3R可用性的降低提示内源性DA增加,与放射性配体竞争。局部D2/3R可用性的变化与在临床上显著体重减轻之前发生的瘦素浓度降低有关。